| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |